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X-linked cone-rod dystrophy (COD1) is a retinal disease that primarily affects the cone photoreceptors; the disease
was originally mapped to a limited region of Xp11.4. We evaluated the three families from our original study with
new markers and clinically reassessed all key recombinants; we determined that the critical intervals in families 2
and 3 overlapped the RP3 locus and that a status change (from affected to probably unaffected) of a key recombinant
individual in family 1 also reassigned the disease locus to include RP3 as well. Mutation analysis of the entire
RPGR coding region identified two different 2-nucleotide (nt) deletions in ORF15, in family 2 (delAG) and in
families 1 and 3 (delGG), both of which result in a frameshift leading to altered amino acid structure and early
termination. In addition, an independent individual with X-linked cone-rod dystrophy demonstrated a 1-nt insertion
(insA) in ORF15. The presence of three distinct mutations associated with the same disease phenotype provides
strong evidence that mutations in RPGR exonORF15 are responsible for COD1. Genetic heterogeneitywas observed
in three other families, including the identification of an in-frame 12-nt deletion polymorphism in ORF15 that did
not segregate with the disease in one of these families.
X-linked cone-rod dystrophy (COD1 [MIM 304020]) is
a rare, progressive visual disease primarily affecting the
cone photoreceptors. Affected individuals (essentially all
of whom are males) present with decreased visual acu-
ity, myopia, photophobia, abnormal color vision, full pe-
ripheral visual fields, decreased photopic electroretino-
graphic responses, and granularity of the macular retinal
pigment epithelium (Pinckers and Timmerman 1981;
Pinckers and Deutman 1987; Jacobson et al. 1989). The
degree of rod-photoreceptor involvement can be variable,
with degeneration increasing as the disease progresses.
Although penetrance appears to be nearly 100%, there
is variable expressivity with respect to age at onset, se-
verity of symptoms, and findings (Hong et al. 1994).
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X-linked retinitis pigmentosa (XLRP [MIM 268000])
is a severe form of inherited retinal degeneration that pri-
marily affects the rod photoreceptors (Bird 1975; Fishman
et al. 1988). It typically causes an early-onset night blind-
ness and loss of peripheral vision, often causing the pa-
tients to become legally blind by the age of 30–40 years.
Of the five current distinct XLRP loci, the twomajor ones
are for retinitis pigmentosa type 2 (RP2 [MIM312600])
and type 3 (RP3 [MIM 312610]), which were mapped
to Xp11.3 (Thiselton et al. 1996; Schwahn et al. 1998)
and Xp21.1 (Meindl et al. 1996; Roepman et al. 1996),
respectively (see the Web site of RetNet). Although RP3
accounts for 170%of XLRP (Ott et al. 1990), the original
retinitis pigmentosa GTPase regulator gene (RPGR), with
19 exons (GenBank accession numbers U57629 and
NM_000328) isolated from the RP3 region, was found
to be mutated in only 10%–27% of families with XLRP
(Meindl et al. 1996; Roepman et al. 1996; Buraczynska
et al. 1997; Zito et al. 2000). Recently, this discrepancy
was resolved by the discovery of a mutational hotspot in
a new 3′ terminal RPGR exon, called “ORF15” (Gen-
Bank accession number AF286472), which was found to
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Table 1










1 348 56 AGGAAGGAGCAGAGGATTCA CCCTCTTCTTCCATTCTTCC
2 444 56 GGGGAGAAAGACAAGGGTAG TCCTTTCCCCTCCTCTACTT
3 982 55 GGAAGAAGGAGACCAAGGAG CCCATTTCCCTGTGTGTTAG
4 414 56 GCAGGATGGAGAGGAGTACA GAGAGAGGCCAAAATTTACCA
NOTE.—The first 152 nts of 5′ end sequence of ORF15 correspond to the original RPGR exon 15, and the previously
described primers for exon 15 were used to amplify this part of the gene (Meindl et al. 1996). The primers in this
table produce four overlapping fragments covering the remaining coding region of ORF15.
be mutated in 60% of patients with XLRP; this suggests
that mutations in RPGR are the only cause of RP3-type
XLRP (Vervoort et al. 2000). The RP15 locus (MIM
300029), which was previously assigned to Xp22 by
linkage analysis of a single pedigree with X-linked dom-
inant cone-rod degeneration (McGuire et al. 1995), was
recently remapped to Xp11.4-p21.1, and a de novo in-
sertion was detected in the RPGR exon ORF15 (Mears
et al. 2000).
COD1 was originally mapped to a region between
Xp11.3 and Xp21.1, encompassing the RP3 locus (Bart-
ley et al. 1989; Jacobson et al. 1989; Bergen et al. 1993,
1994; Hong et al. 1994; Meire et al. 1994). Subsequent
linkage studies, performed by our group through analy-
sis of three families, mapped the disease locus to a limit-
ed region of Xp11.4 between the RP2 and RP3 loci
(DXS993–DXS556), on the basis of the recombinational
events in families 1 and 3 and of the screening results for
the original RPGR transcript (with 19 exons) that were
found to be normal in family 2 (Seymour et al. 1998).
The detailed clinical descriptions and the pedigrees for
these three families have been described elsewhere (Ja-
cobson et al. 1989; Hong et al. 1994; Seymour et al. 1998;
Brown et al. 2000). To further narrow theCOD1 interval,
additional markers were used, and new dinucleotide-re-
peat markers were developed by the identification of the
dinucleotide repeats in the sequences (through use of the
RepeatMasker Web Server) from the genomic clones en-
compassing the DXS993–DXS556 region and by testing
them for a possible polymorphism in selected key indi-
viduals. One of the dinucleotide repeats from GenBank
clone AC069362 (forward primer, 5′-GCCCTTTGGAT-
GAAAGATCC-3′; reverse primer, 5′-TTGCTTCAGCAC-
ACAAGTCA-3′) was found to be polymorphic and in-
formative in both families 1 and 3. BLAST searches re-
vealed that this CA repeat was previously mentioned in
GenBank under the accession number Z67588. This new
repeat marker (the order is tel-DXS556-DXS8042-[new
marker]-DXS574-DXS993-cen) provided the first evi-
dence that the critical intervals for families 1 and 3 were
not overlapping in the original DXS993–DXS556 inter-
val. We clinically reassessed all key recombinants and
evaluated each family individually for possible hetero-
geneity. Since the critical intervals in families 2 and 3 were
still overlappingwith theRP3 locus (Seymour et al. 1998),
RPGR (including the subsequently described alternative
3′ terminal exon ORF15) was reconsidered as a candidate
and was screened for mutations. In family 1, it was dis-
covered that one of the key recombinants (individual 1:
IV:1 [Seymour et al. 1998]), who was initially classified
as “affected” because of his symptoms of photophobia
and poor color vision, was actually found to have normal
central vision with nomacular pathology up to his current
age of 47 years. He was reclassified as “probably unaf-
fected,” and this status change remapped the disease locus
in family 1 to include RP3, as well.
All 19 original exon fragments, plus ORF15 of the
RPGR gene from individuals with COD1, were ampli-
fied from leukocyte genomic DNA and screened for mu-
tations by direct PCR sequencing, through use of either
an ABI377 or ABI3700 sequencer. The intronic primers
and corresponding PCR conditions for the 19 origi-
nal exons have been described elsewhere (Meindl et al.
1996). ORF15 is an alternative 3′ terminal exon that
contains exon 15 and extends into part of intron 15
(Vervoort et al. 2000). It has a 1,706-nucleotide (nt)
coding sequence (567 amino acids with a repetitive do-
main rich in glutamic acid residues), and the first 152
nts of 5′ end sequence corresponds to the originalRPGR
exon 15. In addition to the previously published exon
15 primers, we developed and used four primer pairs to
produce four overlapping fragments covering the re-
maining coding region of ORF15 (table 1).
Mutation analysis identified two different 2-nt dele-
tions in ORF15, in family 2 (1339_1340delAG) and in
families 1 and 3 (1343_1344delGG), both resulting in
a frameshift leading to altered amino acid structure and
early termination (fig. 1a). These mutations were con-
firmed by segregation analysis in the original three large
families. Additionally, a third, unique frameshift muta-
tion (1564_1565insA) was identified in another individ-
ual with X-linked cone-rod dystrophy (fig. 1b). None of
Figure 1 ORF15 mutations and RPGR exon 9 sequence alteration, with the corresponding predicted translation products. The locations for
sequence alterations are indicated by arrows. The partial sequences of ORF15 (a and b) and RPGR exon 9 (c) are shown on the right side of each
chromatogram, with the resulting changes in the open reading frame underlined. a, The 2-nt deletions identified in the original three families, which
cause a frameshift resulting in very similar truncated protein products (46 or 44 novel amino acids, and premature truncation resulting in the loss
of 76 amino acids). b, The 1-nt insertion identified in another individual with X-linked cone-rod dystrophy, which results in three novel amino
acids and in premature truncation resulting in the loss of 43 amino acids. c, A nonconservative amino acid change (Asn345Asp) in RPGR exon 9
(A1092G), which segregated with the mutation in families 1 and 3 and suggests a shared disease haplotype.
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these COD1-related frameshift sequence alterations was
detected in 100 control X chromosomes from unaffected
subjects.
A nonconservative amino acid change (Asn345Asp) in
RPGR exon 9 (A1092G) also segregated with the mu-
tation in families 1 and 3 (fig. 1c). These results are con-
sistent with the shared disease haplotype that we observed
among families 1 and 3 during the linkage analysis (Sey-
mour et al. 1998). The affected males from families 1
and 3 share the same haplotype for RP3, [RPGR ex-
on 9 (A1092G); ORF15 (1343_1344delGG)]-DXS1068-
DXS8025-DXS1058-DXS977-DXS556-DXS8042, cor-
responding to a region that is not shared by recombinant
unaffected individuals. These results suggest that it is
highly likely that these two families are related. The same
RPGR exon 9 missense change was previously reported
in one patient with XLRP and was not detected in 150
control X chromosomes (Sharon et al. 2000). However,
Sharon et al. (2000) considered this change to be a non-
pathogenic variant, since the patient’s affected brother
did not carry this sequence alteration. This missense
change was detected in 2 of 100 control X chromosomes
in the unaffected population we screened, which sup-
ports the previous consideration that it is a rare sequence
variant.
We reconfirmed the existence of genetic heteroge-
neity for X-liked cone-rod dystrophy (Bergen and Pinc-
kers 1997) on the basis of linkage data and the lack
of RPGR-ORF15 mutations in three other families, in-
cluding the observance of an in-frame 12-nt deletion
polymorphism that did not segregate with the disease
in one of these families. This same polymorphism
(1307_1318del12) was also observed in the individual
COD1 sample for which we have found the third mu-
tation (1564_1565insA) that prematurely terminates the
protein. This polymorphism was detected in 6 of 100
control X chromosomes from unaffected subjects.
Our results indicate that mutations in the RPGR exon
ORF15 are the primary cause of COD1, on the basis of
the three independent mutations identified in the set of
families considered here (two of these mutations segre-
gated perfectly with the disease in the three large pedigrees
of five to six generations) that give rise to similar C-ter-
minal truncations in the RPGR-ORF15 protein. In ad-
dition to the already established role of RPGR in XLRP
(a disease that predominantly affects the rod photorecep-
tors), the mutations that we identified in the same gene
appear to primarily affect the cone photoreceptors and to
cause a cone dystrophy phenotype. To the best of our
knowledge, these results represent the first definitive ev-
idence that mutations in RPGR are associated with
COD1. All three COD1mutations that we identifiedwere
in the last 369-nt 3′-end coding sequence of ORF15. In-
terestingly, only one XLRP mutation has been reported
in this region (1344delG [Vervoort et al. 2000]), and the
remaining 31 published ORF15 mutations were detected
within the preceding 5′ region (Mears et al. 2000; Ver-
voort et al. 2000; Yokoyama et al. 2001). Affected males
in the RP15 family (with the 173_174insA mutation
[Mears et al. 2000]) were reported to have early cone
involvement, and the diagnosis for patient 55 (with the
689_692del4 mutation) from Vervoort’s series (Vervoort
et al. 2000) was “probable” X-linked cone dystrophy.
These patients may represent intermediate phenotypes
within the broad spectrum (i.e., between typical XLRP
and typical COD1) of retinal disease caused by RPGR
mutations. Further studies will be necessary to determine
the role of the RPGR exon ORF15 in both rod and cone
photoreceptor functions, as well as its impact on the dis-
ease phenotype.
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